Luminex Corporation was incorporated in May 1995 and began commercial production of the first generation system in 1997. Luminex® (NASDAQ: LMNX) develops, manufactures and markets innovative biological testing technologies with applications throughout the life science and diagnostic industries. The Company’s open-architecture xMAP® Technology enables large numbers of biological tests (bioassays) to be conducted and analyzed quickly, cost-effectively and accurately. Systems using xMAP Technology perform discrete bioassays on the surface of color-coded beads known as microspheres, which are then read in a compact analyzer. Using lasers and high-speed digital-signal processors, the analyzer simultaneously identifies the bioassay and measures the results, all in real time.
Luminex Vision Statement: Breakthrough solutions to improve health and advance science.

Type
Public
HQ
Austin, US
Employees
797 (est)
Luminex has headquartered in Austin, US

Luminex Locations

Austin, US
Madison, US
's-Hertogenbosch, NL
Toronto, CA
Minato-ku, JP
Shanghai, CN

Luminex Metrics

Luminex Summary

Market capitalization

$859 M

Closing share price

$19.5
Luminex's latest market capitalization is $859 M.

Luminex Market Value History

Luminex Online Presence

Luminex Company Life

You may also be interested in